Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Mohamed Saif ElDein
Institutions:
Shaikh Khalifa Medical City,
Abu Dhabi Health Services
Observed institutions:
Shaikh Khalifa Medical City,
Abu Dhabi Health Services
OpenAlex ID:
A5031964569
Safety and immunogenicity of a hybrid-type vaccine booster in BBIBP-CorV recipients in a randomized phase 2 trial
2022
·
Nawal Al Kaabi
, Yun Kai Yang
, et al.
·
Nature Communications
·
39
PDF
Immunogenicity and safety of NVSI-06-07 as a heterologous booster after priming with BBIBP-CorV: a phase 2 trial
2022
·
Nawal Al Kaabi
, Yun Kai Yang
, et al.
·
Signal Transduction and Targeted Therapy
·
32
PDF
Safety and immunogenicity of a mosaic vaccine booster against Omicron and other SARS-CoV-2 variants: a randomized phase 2 trial
2023
·
Nawal Al Kaabi
, Yun Kai Yang
, et al.
·
Signal Transduction and Targeted Therapy
·
10
PDF
Show more works
View as search
Works count:
3
Citation count:
81
H-index:
3
I10-index:
3
Year
Topic
Type
